Related Experiment Video
Updated: May 14, 2026
05:15
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Prospects for prophylactic hepatitis C vaccines based on virus-like particles
Elodie Beaumont1, Philippe Roingeard
11 INSERM U966; Université François Rabelais and CHRU de Tours; Tours, France.
Human Vaccines & Immunotherapeutics
|February 15, 2013
Summary
Developing a prophylactic vaccine against hepatitis C virus (HCV) is crucial due to widespread infection. Promising preclinical results from virus-like particle (VLP) vaccine strategies offer new hope for preventing HCV.
Area of Science:
- Hepatology
- Vaccinology
- Virology
Background:
- Chronic hepatitis C virus (HCV) infection poses a significant global health challenge with severe long-term complications.
- Despite treatment advancements, millions are newly infected annually, necessitating preventative strategies.
- A prophylactic vaccine for HCV is a critical medical priority.
Purpose of the Study:
- To review the current status of prophylactic hepatitis C virus (HCV) vaccines.
- To identify challenges hindering vaccine development and deployment.
- To explore emerging virus-like particle (VLP)-based vaccination approaches.
Main Methods:
- Review of current scientific literature on HCV vaccine development.
- Analysis of preclinical trial data for VLP-based vaccine candidates.
- Discussion of scientific, logistical, and bioethical hurdles in vaccine research.
Main Results:
- Limited clinical data exists for current HCV vaccine candidates, highlighting efficacy and safety concerns.
- Recent innovations in vaccine formulation, delivery, and technology are advancing the field.
- Preclinical studies of VLP-based HCV vaccines show highly promising results.
Conclusions:
- Virus-like particle (VLP) based vaccination strategies represent a promising avenue for prophylactic HCV vaccine development.
- Overcoming existing challenges is essential for advancing HCV vaccines to clinical application.
- Continued innovation in vaccine technology is key to developing an effective HCV vaccine.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...